Aggregating cardiac resynchronization therapy data
    3.
    发明授权
    Aggregating cardiac resynchronization therapy data 有权
    聚集心脏再同步治疗数据

    公开(公告)号:US08862212B2

    公开(公告)日:2014-10-14

    申请号:US13316177

    申请日:2011-12-09

    IPC分类号: A61B5/0402 G06F19/00

    摘要: Cardiac resynchronization therapy (CRT) performance data for a number of patients in which an implantable medical device (IMD) is implanted is aggregated and reports of the aggregated data are generated, e.g., for review by organizations or individual clinicians treating the patients. In one example, a method includes collecting CRT performance data correlated to cardiac rhythm event data for a first group of patients in which an IMD configured to deliver CRT is implanted, aggregating, with a computing device, the CRT performance data correlated to the cardiac rhythm event data for a second group of patients from among the first group of patients, and generating, with the computing device, a report comprising the aggregation of the CRT performance data correlated to the cardiac rhythm event data for the second group of patients.

    摘要翻译: 对植入了植入式医疗装置(IMD)的许多患者的心脏再同步治疗(CRT)性能数据进行聚合,并且生成聚合数据的报告,例如用于治疗患者的组织或个体临床医师的审查。 在一个示例中,一种方法包括收集与其中植入用于递送CRT的IMD相关的第一组患者的与心律事件数据相关的CRT性能数据,与计算设备聚合与心律相关的CRT性能数据 生成来自第一组患者的第二组患者的事件数据,并且与计算设备一起生成包括与第二组患者的心律事件数据相关的CRT性能数据的聚集的报告。

    ELECTROGRAM SUMMARY
    4.
    发明申请
    ELECTROGRAM SUMMARY 有权
    电机概要

    公开(公告)号:US20130085403A1

    公开(公告)日:2013-04-04

    申请号:US13250515

    申请日:2011-09-30

    摘要: The present disclosure is directed to an electrogram summary. In various examples, a subset of cardiac episodes are selected and displayed based on a set of summary rules. The subset of cardiac episodes includes at least one episode from each of a plurality of episode categories with at least one cardiac episode. In some examples, the order in which the cardiac episodes selected are displayed is based on the set of summary rules. The electrogram summary may include images or information regarding each of the selected cardiac episodes.

    摘要翻译: 本公开涉及电描记图。 在各种示例中,基于一组汇总规则来选择和显示心脏发作的一个子集。 心脏发作的子集包括来自具有至少一个心脏发作的多个发作类别中的每一个的至少一个情节。 在一些示例中,显示所选择的心脏发作的顺序是基于汇总规则的集合。 电描记图可以包括关于所选心脏发作中的每一个的图像或信息。

    HEART FAILURE MONITORING
    5.
    发明申请
    HEART FAILURE MONITORING 审中-公开
    心力衰竭监测

    公开(公告)号:US20120253207A1

    公开(公告)日:2012-10-04

    申请号:US13436408

    申请日:2012-03-30

    IPC分类号: A61B5/0205

    摘要: Techniques for transmitting diagnostic information stored in an implantable medical device (IMD) based on patient hospitalization are described. For example, the IMD may transmit higher resolution diagnostic information to a clinician and/or an external device during a hospitalization period to aid the clinician in evaluating heart failure treatment and when discharge is proper. This higher resolution diagnostic information may include one or more patient metrics automatically generated and transmitted by the IMD at least once every two hours. During a post-hospitalization period, the IMD may transmit lower resolution diagnostic information to a clinician that indicates a risk level of re-hospitalization. The lower resolution diagnostic information may include the risk level and/or patient metrics once a day, for example. In this manner, the IMD transmitted diagnostic information may be tailored to the specific heart failure monitoring needed by the patient.

    摘要翻译: 描述了基于患者住院时间传送存储在可植入医疗装置(IMD)中的诊断信息的技术。 例如,IMD可以在住院期间向临床医师和/或外部设备传送更高分辨率的诊断信息,以帮助临床医师评价心力衰竭治疗以及放电是否合适。 该更高分辨率的诊断信息可以包括由IMD自动生成和发送的至少每两小时一次的一个或多个患者度量。 在住院后期间,IMD可以向临床医生传递较低分辨率的诊断信息,指示重新住院的风险水平。 例如,较低分辨率诊断信息可以包括一天一次的风险水平和/或患者度量。 以这种方式,IMD传输的诊断信息可以针对患者所需的特定心力衰竭监测。

    REDUCING INAPPROPRIATE DELIVERY OF THERAPY FOR SUSPECTED NON-LETHAL ARRHYTHMIAS
    6.
    发明申请
    REDUCING INAPPROPRIATE DELIVERY OF THERAPY FOR SUSPECTED NON-LETHAL ARRHYTHMIAS 有权
    减少不合理的非精神病人的治疗方法

    公开(公告)号:US20110172727A1

    公开(公告)日:2011-07-14

    申请号:US13053625

    申请日:2011-03-22

    IPC分类号: A61N1/365

    摘要: An implantable medical device (IMD) identifies suspected non-lethal ventricular arrhythmia, and takes one or more actions in response to the identification to avoid or delay delivery of a defibrillation or cardioversion shock. The IMD employs number of intervals to detect (NID) thresholds for detection of ventricular arrhythmias. When a NID threshold is met, the IMD determines whether the ventricular rhythm is a suspected non-lethal rhythm despite satisfying a NID threshold. In some embodiments, the IMD increases the NID threshold, i.e., extends the time for detection, in response to identifying a rhythm as a suspected non-lethal rhythm, and monitors subsequent ventricular beats to determine if the increased NID threshold is met before detecting a ventricular arrhythmia and delivering therapy. The IMD can determine whether a rhythm is a suspected non-lethal arrhythmia by, for example, comparing the median ventricular cycle length (VCL) to the median atrial cycle length (ACL).

    摘要翻译: 植入式医疗器械(IMD)识别疑似非致死性室性心律失常,并采取一项或多项行动来回应识别,以避免或延迟除颤或复律性休克的传播。 IMD采用间隔数来检测(NID)阈值以检测室性心律失常。 当满足NID阈值时,即使满足NID阈值,IMD确定心室节律是否是怀疑的非致命节律。 在一些实施例中,响应于将节律识别为怀疑非致命节律,IMD增加NID阈值,即扩展检测时间,并且监测随后的心室搏动以确定在检测到之前是否满足增加的NID阈值 室性心律失常和输送治疗。 IMD可以通过例如比较心室中心周期长度(VCL)与中位心房周期长度(ACL)来确定节律是否是怀疑是非致死性心律失常。

    Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device
    7.
    发明授权
    Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device 有权
    用于控制可植入医疗装置中的高电压和抗速度起搏治疗递送的方法和装置

    公开(公告)号:US06718204B2

    公开(公告)日:2004-04-06

    申请号:US09918224

    申请日:2001-07-30

    IPC分类号: A61N108

    摘要: A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.

    摘要翻译: 公开了一种用于响应于异常心律的检测而提供抗起搏起搏(ATP)治疗和高压休克疗法的系统和方法。 该系统基于预定的一组标准来控制ATP治疗与高压电容器的充电之间的时间,以准备冲击输送。 在一个实施例中,本发明的系统在ATP电容器充电(ATP-DCC)模式下工作,其中在高压电容器充电期间全部或基本上全部ATP治疗被递送。 基于对预定标准集合的评估,系统可以切换到在电容器充电(ATP-BCC)模式之外的另外的ATP,其中在高压电容器充电之前基本上全部ATP治疗被递送。 根据本发明的一个方面,预定的一组标准至少部分地基于先前传递的ATP治疗的有效性。

    Reducing inappropriate delivery of therapy for suspected non-lethal arrhythmias

    公开(公告)号:US08594786B2

    公开(公告)日:2013-11-26

    申请号:US13053625

    申请日:2011-03-22

    IPC分类号: A61N1/365

    摘要: An implantable medical device (IMD) identifies suspected non-lethal ventricular arrhythmia, and takes one or more actions in response to the identification to avoid or delay delivery of a defibrillation or cardioversion shock. The IMD employs number of intervals to detect (NID) thresholds for detection of ventricular arrhythmias. When a NID threshold is met, the IMD determines whether the ventricular rhythm is a suspected non-lethal rhythm despite satisfying a NID threshold. In some embodiments, the IMD increases the NID threshold, i.e., extends the time for detection, in response to identifying a rhythm as a suspected non-lethal rhythm, and monitors subsequent ventricular beats to determine if the increased NID threshold is met before detecting a ventricular arrhythmia and delivering therapy. The IMD can determine whether a rhythm is a suspected non-lethal arrhythmia by, for example, comparing the median ventricular cycle length (VCL) to the median atrial cycle length (ACL).

    Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device
    9.
    发明授权
    Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device 有权
    用于控制可植入医疗装置中的高电压和抗速度起搏治疗递送的方法和装置

    公开(公告)号:US08170663B2

    公开(公告)日:2012-05-01

    申请号:US11687282

    申请日:2007-03-16

    IPC分类号: A61N1/362 A61N1/39

    摘要: A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.

    摘要翻译: 公开了一种用于响应于异常心律的检测而提供抗起搏起搏(ATP)治疗和高压休克疗法的系统和方法。 该系统基于预定的一组标准来控制ATP治疗与高压电容器的充电之间的时间,以准备冲击输送。 在一个实施例中,本发明的系统在ATP电容器充电(ATP-DCC)模式下工作,其中在高压电容器充电期间全部或基本上全部ATP治疗被递送。 基于对预定标准集合的评估,系统可以切换到在电容器充电(ATP-BCC)模式之外的另外的ATP,其中在高压电容器充电之前基本上全部ATP治疗被递送。 根据本发明的一个方面,预定的一组标准至少部分地基于先前传递的ATP治疗的有效性。